BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silaghi CA, Lozovanu V, Georgescu CE, Georgescu RD, Susman S, Năsui BA, Dobrean A, Silaghi H. Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:649522. [PMID: 34054725 DOI: 10.3389/fendo.2021.649522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Velez Torres JM, Tjendra Y, Kerr DA. A Triumvirate:: Correlating Thyroid Cytopathology, Molecular Testing, and Histopathology. Surg Pathol Clin 2023;16:1-14. [PMID: 36739157 DOI: 10.1016/j.path.2022.09.003] [Reference Citation Analysis]
2 Alohali S, Payne AE, Pusztaszeri M, Rajab M, Forest VI, Hier MP, Tamilia M, Payne RJ. Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations. Cancers (Basel) 2023;15. [PMID: 36672362 DOI: 10.3390/cancers15020413] [Reference Citation Analysis]
3 McMurtry V, Canberk S, Deftereos G. Molecular testing in fine-needle aspiration of thyroid nodules. Diagn Cytopathol 2023;51:36-50. [PMID: 36480743 DOI: 10.1002/dc.25035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lukyanov SA, Sergiyko SV, Ilyina TE. Post-transcriptional micro-RNAs in diagnostics and personalization of treatment in patients with thyroid tumors: literary review. Perm Medical Journal 2022;39:80-92. [DOI: 10.17816/pmj39580-92] [Reference Citation Analysis]
5 Rajab M, Payne RJ, Forest V, Pusztaszeri M. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada. Cancers 2022;14:4140. [DOI: 10.3390/cancers14174140] [Reference Citation Analysis]
6 Houten PV, Netea-Maier RT, Smit JW. Differentiated thyroid carcinoma: An update. Best Pract Res Clin Endocrinol Metab 2022;:101687. [PMID: 36002346 DOI: 10.1016/j.beem.2022.101687] [Reference Citation Analysis]
7 Zaichick V. Diagnosis of Thyroid Malignancy using Levels of Chemical Element Contents in Nodular Tissue. J Health Care and Research 2022;3:16-30. [DOI: 10.36502/2022/hcr.6207] [Reference Citation Analysis]
8 Napoli F, Rapa I, Mortara U, Massa F, Izzo S, Rigutto A, Zambelli V, Bellevicine C, Troncone G, Papotti M, Volante M. MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting. Cancer Cytopathol 2022. [PMID: 35500065 DOI: 10.1002/cncy.22585] [Reference Citation Analysis]
9 Zaichick V. Distinguish Thyroid Malignant from Benign Alterations using Trace Element Contents in Nodular Tissue determined by Neutron Activation and Inductively Coupled Plasma Mass Spectrometry. JCDP 2022;1:18-33. [DOI: 10.14302/issn.2689-5773.jcdp-22-4123] [Reference Citation Analysis]
10 Macerola E, Poma AM, Proietti A, Rago T, Romani R, Vignali P, Ugolini C, Torregrossa L, Basolo A, Santini F, Basolo F. Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations. Endocrine. [DOI: 10.1007/s12020-022-03034-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Douek M. Radiofrequency ablation of solid, non-functional thyroid nodules. Techniques in Vascular and Interventional Radiology 2022. [DOI: 10.1016/j.tvir.2022.100821] [Reference Citation Analysis]
12 Belousov PV. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges. Biomedicines 2022;10:468. [DOI: 10.3390/biomedicines10020468] [Reference Citation Analysis]
13 Ohori NP. A decade into thyroid molecular testing: where do we stand? Journal of the American Society of Cytopathology 2021. [DOI: 10.1016/j.jasc.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gild ML, Chan M, Gajera J, Lurie B, Gandomkar Z, Clifton-Bligh RJ. Risk stratification of indeterminate thyroid nodules using ultrasound and machine learning algorithms. Clin Endocrinol (Oxf) 2021. [PMID: 34642976 DOI: 10.1111/cen.14612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]